
Insider buying is a flimsy market signal without some other catalyst to drive the price action. In the case of TriSalus Life Sciences (NASDAQ: TLSI), Avadel Pharmaceuticals (NASDAQ: AVDL), and Smithfield Foods (NASDAQ: SFD), there is another catalyst: growth. These unrelated companies have unique catalysts to drive revenue and earnings growth in 2025, are undervalued relative to analysts' targets, peers, or both, and the insiders are buying them.